Patients help redesign clinical trials to boost diversity
NCT ID NCT06469307
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times
Summary
This study aims to make clinical trials more inclusive by training 40 adults who are in remission from blood cancer to review and give feedback on trial plans. The goal is to see if this community-based review process is practical and acceptable. The study does not test a new treatment but focuses on improving how research is done.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Tumor's DNA guide better cancer care for kids?
- Could gratitude exercises aid blood cancer recovery?
- Can donor immune cells be engineered to fight blood cancer?
- A guided path back to work after blood cancer: a trial tests the impact
- Can a new tracer light up cancer growth?
- Can a different immune drug cut viral infections after stem cell transplants?